Skip to content Skip to footer
Subscribe Now
Viewpoints_Joe Eazor
VIEWPOINTS

PharmaShots Interview: Clario’s Joe Eazor Shares Insight on the Clinical Trial Innovation and Evidence

In an interview with PharmaShots, Joe Eazor, CEO at Clario share his views on the ERT’s merger with Bioclinica to become Clario for clinical trial innovation and evidence ERT & Bioclinica merged to become Clario, following its Apr 2021 merger agreement & to generate the clinical evidence, empower the patients &  transform their lives by providing better evidence Clario combines Bioclinica's expertise in imaging,…
December 30, 2021

Read more

Viewpoints_Shannon Burke
VIEWPOINTS

PharmaShots Interview: Synchrony’s Shannon Burke Shares Insight on Healthcare Consumerism

In an interview with PharmaShots, Shannon Burke, Synchrony Senior Vice President, and General Manager, Health Systems, share her views on healthcare financing & empowers the patients to pay for their healthcare Synchrony’s CareCredit card is a comprehensive healthcare financial solution that is designed for health and wellness needs. The CareCredit solution helps health systems, reduce accounts receivable, increase revenue,…
December 29, 2021

Read more

Viewpoints_Andrew Hall
VIEWPOINTS

PharmaShots Interview: IMV’s Andrew Hall Shares Insight on DPX Technology for Bladder and Ovarian Cancer

In an interview with PharmaShots, Andrew Hall, CEO at IMV share his views on the data of  DPX delivery platform in the bladder and ovarian cancer, presented in two e-posters at the AACR-NCI-EORTC virtual conference Shots: The company has reported additional data to support the immunotherapeutic capabilities of its DPX technology. In pre-clinical/clinical data, DPX technology generates peptide-specific, T cell-based immune…
December 28, 2021

Read more

Exclusive_Jeremiah Robison_2021
EXCLUSIVE

Exclusive Interview with PharmaShots: Jeremiah Robison of Cionic Share Insight on the New Data of Neural Sleeve for Neurological & other Disorders

In an interview with PharmaShots, Jeremiah Robison, Founder, and CEO at Cionic shared his views on the data of the Neural Sleeve gait study for patients with cerebral palsy, MS, stroke, and other neurological disorders Shots: Cionic has reported the results from the Neural Sleeve gait study which was conducted in the San Francisco Bay Area. The study showed an…
December 27, 2021

Read more

Viewpoints_Matt Walz
VIEWPOINTS

PharmaShots Interview: Trialbee’s Matt Walz Shares Insight on Trialbee Honey Platform

In an interview with PharmaShots, Matt Walz, CEO at Trialbee share his views on the launch of the Trialbee Honey platform to empower patient recruitment Shots: Trialbee launched Trialbee Honey that allows to track, measure, and analyze all patient enrollment activities in clinical trials The platform is designed to address clinical research and trial barriers by using data to optimize the patient experience,…
December 22, 2021

Read more

Viewpoints_Anthony Ho
VIEWPOINTS

PharmaShots Interview: QIAGEN’s Anthony Ho Shares Insight on the US Government Contract to Boost the Production of PCR Tests for NeuMoDx Systems

In an interview with PharmaShots, Anthony Ho, Global Head of Strategic Planning for Molecular Diagnostics at QIAGEN share his views on the winner of the $3.4M US DOD contract to increase the production of COVID-19 PCR test Shots: QIAGEN has received a $3.4M contract from the US DOD in coordination with the Department of HHS to increase the production capacity for…
December 21, 2021

Read more

Viewpoints_Meghan Scanlon
VIEWPOINTS

PharmaShots Interview: Boston Scientific’s Meghan Scanlon Shares Insight on the Completion of its $1.07B Lumenis Acquisition

In an interview with PharmaShots, Meghan Scanlon, Senior Vice President and President for Urology and Pelvic Health at Boston Scientific shares her views on the completion of its $1.07B  acquisition of Lumenis surgical business Shots: Boston Scientific reported the closing of its acquisition of the Lumenis surgical business from a BPEA affiliate for an upfront of $1.07B. The acquisition follows the Mar…
December 20, 2021

Read more

Viewpoints_Thierry Abribat
VIEWPOINTS

PharmaShots Interview: Amolyt Pharma’s Thierry Abribat Shares Insight on the Data of AZP-3601 for Hypoparathyroidism

In an interview with PharmaShots, Thierry Abribat, Founder and Chief Executive Officer at Amolyt Pharma shares his views on the data from the P-I trial of AZP-3601 for the treatment of Hypoparathyroidism Shots: The P-I trial evaluates the safety, tolerability, PK, PD, and preliminary efficacy of AZP-3601 in 102 healthy volunteers including 52 in the SAD and 50 in the MAD cohorts…
December 15, 2021

Read more

Viewpoints_Neil Moat
VIEWPOINTS

PharmaShots Interview: Abbott’s Neil Moat Shares Insight on the US FDA’s Approval of Epic Plus Tissue Valves for Mitral or Aortic Valve Replacement

In an interview with PharmaShots, Neil Moat, MD, DVP Medical Affairs, Chief Medical Officer at Abbott's shares his views on the Epic Plus Tissue Valves approval for the treatment of mitral or aortic valve replacement The US FDA has approved Epic Plus & Epic Plus Supra Stented Tissue Valves to improve therapy options for patients with aortic or mitral valve…
December 14, 2021

Read more

Load more